A share price of Hims & Hers Health Inc [HIMS] is currently trading at $17.27, up 5.05%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HIMS shares have gain 7.27% over the last week, with a monthly amount glided 3.23%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on August 22, 2024, when Needham initiated its Buy rating and assigned the stock a price target of $24. Previously, Imperial Capital downgraded its rating to In-line on August 09, 2024. On May 22, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $20 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $15 on April 16, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $20 as its price target on April 10, 2024. Imperial Capital upgraded its rating to Outperform for this stock on February 28, 2024, but kept the price target unchanged to $16. In a note dated February 26, 2024, Leerink Partners initiated an Market Perform rating and provided a target price of $10 on this stock.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $5.65 and $25.74. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $17.27 at the most recent close of the market. An investor can expect a potential drop of -7.35% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 1.07B which represents 51.82% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.05 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.66 points at the first support level, and at 16.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.59, and for the 2nd resistance point, it is at 17.90.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 2.68. In addition, the Quick Ratio stands at 2.30 and the Cash Ratio stands at 1.19. Considering the valuation of this stock, the price to sales ratio is 3.50, the price to book ratio is 10.34 and price to earnings (TTM) ratio is 230.88.
Transactions by insiders
Recent insider trading involved Okupe Oluyemi, Chief Financial Officer, that happened on Sep 20 ’24 when 12651.0 shares were sold. Chief Executive Officer, Dudum Andrew completed a deal on Sep 20 ’24 to sell 45767.0 shares. Meanwhile, Officer Andrew Dudum bought 0.69 million shares on Sep 20 ’24.
